| scholarly article | Q13442814 |
| P50 | author | Kelly Arnold | Q57439800 |
| Douglas A. Lauffenburger | Q59755238 | ||
| Florencia Pereyra | Q72530851 | ||
| Daniel Kuritzkes | Q88453812 | ||
| Galit Alter | Q88683228 | ||
| Janet Lo | Q89839794 | ||
| Anne-Sophie Dugast | Q90440217 | ||
| P2093 | author name string | Jonathan Z Li | |
| Steven Grinspoon | |||
| Jill Plants | |||
| Alan Landay | |||
| Heather J Ribaudo | |||
| Kelly B Arnold | |||
| Kevin Cesa | |||
| Andrea Heisey | |||
| P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| HIV infection and the risk of acute myocardial infarction | Q27347231 | ||
| CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory | Q28477861 | ||
| The major genetic determinants of HIV-1 control affect HLA class I peptide presentation | Q29417018 | ||
| HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 | ||
| Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. | Q33649753 | ||
| Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria. | Q33751658 | ||
| Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. | Q33962303 | ||
| Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial | Q35006056 | ||
| Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers | Q35018065 | ||
| Factors associated with D-dimer levels in HIV-infected individuals | Q35120065 | ||
| Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients | Q35465943 | ||
| The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women | Q35857580 | ||
| The macrophage scavenger receptor CD163. | Q36257860 | ||
| Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy | Q36304297 | ||
| Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection | Q36330954 | ||
| Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers | Q36862952 | ||
| Arterial inflammation in patients with HIV. | Q37046942 | ||
| Higher expression of several interferon-stimulated genes in HIV-1-infected females after adjusting for the level of viral replication. | Q37070383 | ||
| Disease Progression in HIV-1-Infected Viremic Controllers | Q37077305 | ||
| Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control | Q37169129 | ||
| Effect of antiretroviral therapy on HIV reservoirs in elite controllers | Q37212990 | ||
| Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis | Q37215251 | ||
| Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women | Q37272371 | ||
| Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease | Q37390635 | ||
| Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration | Q37490654 | ||
| Evidence for innate immune system activation in HIV type 1-infected elite controllers. | Q37604465 | ||
| In vivo systems analysis identifies spatial and temporal aspects of the modulation of TNF-α-induced apoptosis and proliferation by MAPKs | Q37657176 | ||
| Soluble biomarkers of HIV transmission, disease progression and comorbidities | Q38070308 | ||
| Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors | Q38748887 | ||
| IL-4 and a glucocorticoid up-regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV-1 replication | Q39574232 | ||
| Interleukin-4 inhibits an early phase in the HIV-1 life cycle in the human colorectal cell line HT-29. | Q39755352 | ||
| HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term. | Q41762711 | ||
| Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection. | Q42212835 | ||
| Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters | Q43070781 | ||
| Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study | Q44429168 | ||
| Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load | Q45733056 | ||
| Sustained high levels of serum interferon-γ during HIV-1 infection: a specific trend different from other cytokines | Q46256467 | ||
| Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens | Q46484253 | ||
| Projected life expectancy of people with HIV according to timing of diagnosis | Q57476832 | ||
| TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study | Q57605852 | ||
| Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients | Q61365330 | ||
| Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients | Q61767187 | ||
| The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication | Q71930009 | ||
| IL-4 and IL-13 have overlapping but distinct effects on HIV production in monocytes | Q72691332 | ||
| Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection | Q73486184 | ||
| Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection | Q80433518 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | demographics | Q2725376 |
| P304 | page(s) | ofu117 | |
| P577 | publication date | 2015-01-13 | |
| P1433 | published in | Open Forum Infectious Diseases | Q27725953 |
| P1476 | title | Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics | |
| P478 | volume | 2 |
| Q52680990 | Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers. |
| Q28468505 | Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV Infection |
| Q57825309 | Current Treatment Options for HIV Elite Controllers: a Review |
| Q38988925 | Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology |
| Q47174478 | Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection. |
| Q55400910 | High Plasma Levels of sTNF-R1 and CCL11 Are Related to CD4+ T-Cells Fall in Human Immunodeficiency Virus Elite Controllers With a Sustained Virologic Control. |
| Q56334211 | Increased Systemic Inflammation and Gut Permeability Among Women With Treated HIV Infection in Rural Uganda |
| Q39113783 | Increased frequencies of CD8+CD57+ T cells are associated with antibody neutralization breadth against HIV in viraemic controllers |
| Q33828507 | Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers |
| Q38832560 | Neurologic Complications in Treated HIV-1 Infection |
| Q38414358 | Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered |
| Q64266997 | No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial |
| Q36638690 | Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts |
| Q89556610 | Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure |
| Q92456846 | Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting |
| Q37294964 | Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV. |
| Q56996082 | Sex Differences in HIV Infection: Mystique Versus Machismo |
| Q47597201 | Sex Differences in Select Non-communicable HIV-Associated Comorbidities: Exploring the Role of Systemic Immune Activation/Inflammation |
| Q58104425 | Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation |
| Q57177414 | Understanding the CD8 T-cell response in natural HIV control |
Search more.